BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19460428)

  • 1. The structurally similar, penta-acylated lipopolysaccharides of Porphyromonas gingivalis and Bacteroides elicit strikingly different innate immune responses.
    Berezow AB; Ernst RK; Coats SR; Braham PH; Karimi-Naser LM; Darveau RP
    Microb Pathog; 2009 Aug; 47(2):68-77. PubMed ID: 19460428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria.
    Coats SR; Berezow AB; To TT; Jain S; Bainbridge BW; Banani KP; Darveau RP
    Infect Immun; 2011 Jan; 79(1):203-10. PubMed ID: 20974832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of human {beta}-defensins expression in human gingival epithelia by Porphyromonas gingivalis lipopolysaccharide with tetra- and penta-acylated lipid A structures.
    Lu Q; Darveau RP; Samaranayake LP; Wang CY; Jin L
    Innate Immun; 2009 Dec; 15(6):325-35. PubMed ID: 19675119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PGN_1123 as the Gene Encoding Lipid A Deacylase, an Enzyme Required for Toll-Like Receptor 4 Evasion, in Porphyromonas gingivalis.
    Jain S; Chang AM; Singh M; McLean JS; Coats SR; Kramer RW; Darveau RP
    J Bacteriol; 2019 Jun; 201(11):. PubMed ID: 30782639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts.
    Herath TD; Darveau RP; Seneviratne CJ; Wang CY; Wang Y; Jin L
    PLoS One; 2013; 8(3):e58496. PubMed ID: 23554896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunomodulation by lipophilic termini of lipopolysaccharide; synthesis of lipid As from Porphyromonas gingivalis and other bacteria and their immunomodulative responses.
    Fujimoto Y; Shimoyama A; Saeki A; Kitayama N; Kasamatsu C; Tsutsui H; Fukase K
    Mol Biosyst; 2013 May; 9(5):987-96. PubMed ID: 23429860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition.
    Reife RA; Coats SR; Al-Qutub M; Dixon DM; Braham PA; Billharz RJ; Howald WN; Darveau RP
    Cell Microbiol; 2006 May; 8(5):857-68. PubMed ID: 16611234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A.
    Ogawa T; Asai Y; Makimura Y; Tamai R
    Front Biosci; 2007 May; 12():3795-812. PubMed ID: 17485340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis LPS stimulates the expression of LPS-binding protein in human oral keratinocytes in vitro.
    Ding PH; Wang CY; Darveau RP; Jin L
    Innate Immun; 2013 Feb; 19(1):66-75. PubMed ID: 22736337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylation of Porphyromonas gingivalis LPS and its effect on bacterial-host interactions.
    Zaric SS; Lappin MJ; Fulton CR; Lundy FT; Coulter WA; Irwin CR
    Innate Immun; 2017 Apr; 23(3):319-326. PubMed ID: 28205451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50.
    Rangarajan M; Aduse-Opoku J; Paramonov N; Hashim A; Bostanci N; Fraser OP; Tarelli E; Curtis MA
    J Bacteriol; 2008 Apr; 190(8):2920-32. PubMed ID: 18263730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide.
    Al-Qutub MN; Braham PH; Karimi-Naser LM; Liu X; Genco CA; Darveau RP
    Infect Immun; 2006 Aug; 74(8):4474-85. PubMed ID: 16861633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis.
    Sawada N; Ogawa T; Asai Y; Makimura Y; Sugiyama A
    Clin Exp Immunol; 2007 Jun; 148(3):529-36. PubMed ID: 17335558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses.
    Curtis MA; Percival RS; Devine D; Darveau RP; Coats SR; Rangarajan M; Tarelli E; Marsh PD
    Infect Immun; 2011 Mar; 79(3):1187-93. PubMed ID: 21220483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide.
    Ogawa T
    FEBS Lett; 1993 Oct; 332(1-2):197-201. PubMed ID: 8405442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemical structure and immunobiological activity of Bacteroides species LPS based on study of Porphyromonas gingivalis LPS].
    Ogawa T
    Nihon Saikingaku Zasshi; 2006 Nov; 61(4):391-404. PubMed ID: 17191694
    [No Abstract]   [Full Text] [Related]  

  • 17. Variants of Porphyromonas gingivalis lipopolysaccharide alter lipidation of autophagic protein, microtubule-associated protein 1 light chain 3, LC3.
    Blasi I; Korostoff J; Dhingra A; Reyes-Reveles J; Shenker BJ; Shahabuddin N; Alexander D; Lally ET; Bragin A; Boesze-Battaglia K
    Mol Oral Microbiol; 2016 Dec; 31(6):486-500. PubMed ID: 26452236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity differentially modulates the expression of IL-6 and IL-8 in human gingival fibroblasts.
    Herath TD; Wang Y; Seneviratne CJ; Lu Q; Darveau RP; Wang CY; Jin L
    J Clin Periodontol; 2011 Aug; 38(8):694-701. PubMed ID: 21752043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
    Slocum C; Coats SR; Hua N; Kramer C; Papadopoulos G; Weinberg EO; Gudino CV; Hamilton JA; Darveau RP; Genco CA
    PLoS Pathog; 2014 Jul; 10(7):e1004215. PubMed ID: 25010102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex.
    Coats SR; Pham TT; Bainbridge BW; Reife RA; Darveau RP
    J Immunol; 2005 Oct; 175(7):4490-8. PubMed ID: 16177092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.